Should We Rely on the Findings of Each Published Randomized Controlled Study?

authors:

avatar Ali Kabir 1 , *

Department of Epidemiology, Faculty of Public Health, Shahid Beheshti University of Medical Sciences, Center for Educational Research in Medical Sciences, Tehran University of Medical Sciences, Tehran, IR Iran

how to cite: Kabir A. Should We Rely on the Findings of Each Published Randomized Controlled Study?. Hepat Mon. 2013;13(3):e8355. https://doi.org/10.5812/hepatmon.8355.

References

  • 1.

    Salt WB, 2nd. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. J Insur Med. 2004;36(1):27-41. [PubMed ID: 15104027].

  • 2.

    Hajiaghamohammadi AA, Ziaee A, Oveisi S, Masroor H. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. Hepat Mon. 2012;12(8). e6099. [PubMed ID: 23087748]. https://doi.org/10.5812/hepatmon.6099.

  • 3.

    Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996;86(5):726-8. [PubMed ID: 8629727].

  • 4.

    The CONSORT Statement. Available from: http://www.consort-statement.org/consort-statement/overview0/.

  • 5.

    Jamali R, Pourshams A, Amini S, Deyhim MR, Rezvan H, Malekzadeh R. The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med. 2008;11(6):602-7. [PubMed ID: 18976029].